{"transactions":[{"id":702520,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2026-07-28T20:24:28.000Z","date":"2026-07-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":53266,"price":1.22,"value":64984.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of common stock par value $0.01 per shares of OPKO Health, Inc. withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."}],"balance_after":563396,"source":{"system":"sec-edgar","filing":"0001193125-26-321055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000119312526321055/ownership.xml","form_type":"4"}},{"id":1131024,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T21:03:30.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 27, 2026."}],"balance_after":437500,"derivative":{"exercise_price":1.31,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0000950170-25-079109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017025079109/ownership.xml","form_type":"4"}},{"id":1448289,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2024-07-26T23:15:29.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The\nrestricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years."}],"balance_after":616662,"source":{"system":"sec-edgar","filing":"0000950170-24-087036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024087036/ownership.xml","form_type":"4"}},{"id":1717704,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-08T22:30:08.000Z","date":"2023-12-06","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":4.29,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001683168-23-008735","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316823008735/ownership.xml","form_type":"4"}},{"id":1885618,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-19T20:36:54.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 18, 2024."}],"balance_after":700000,"derivative":{"exercise_price":1.58,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-23-031032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123031032/doc4.xml","form_type":"4"}},{"id":2091034,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-09T22:04:11.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.4367,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-22-008324","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316822008324/ownership.xml","form_type":"4"}},{"id":2478813,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-10T01:09:31.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.44,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-21-006234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316821006234/ownership.xml","form_type":"4"}},{"id":2844240,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-22T21:11:02.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning February 19, 2022."}],"balance_after":350000,"derivative":{"exercise_price":4.81,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-21-012672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919121012672/doc4.xml","form_type":"4"}},{"id":2953253,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-12-08T22:04:47.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.1,"expiration_date":"2030-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-20-004206","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316820004206/ownership.xml","form_type":"4"}},{"id":3119239,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T20:13:19.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning June 4, 2021."}],"balance_after":350000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-20-034957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919120034957/doc4.xml","form_type":"4"}},{"id":3349663,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-06T23:39:35.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest 100% on the twelve month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001683168-19-003921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000168316819003921/ownership.xml","form_type":"4"}},{"id":3469096,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T17:03:57.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning July 1, 2020."}],"balance_after":250000,"derivative":{"exercise_price":2.47,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-19-040728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119040728/doc4.xml","form_type":"4"}},{"id":3532192,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2019-05-10T10:13:43.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":3150,"price":2.04,"value":6426.0,"ownership":{"direct":true},"balance_after":179162,"source":{"system":"sec-edgar","filing":"0001209191-19-028668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119028668/doc4.xml","form_type":"4"}},{"id":3532191,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2019-05-10T10:13:43.000Z","date":"2019-05-09","kind":"purchase","acquired":true,"shares":100,"price":2.035,"value":203.5,"ownership":{"direct":true},"balance_after":176012,"source":{"system":"sec-edgar","filing":"0001209191-19-028668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919119028668/doc4.xml","form_type":"4"}},{"id":3747473,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-30T22:23:11.000Z","date":"2018-11-28","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options vest in equal quarterly installments over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":3.05,"expiration_date":"2028-11-28","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001662252-18-000105","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225218000105/ownership.xml","form_type":"4"}},{"id":3885436,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T20:13:39.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 21, 2018 and vest annually in four equal installments beginning on June 21, 2019."}],"balance_after":300000,"derivative":{"exercise_price":4.46,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-18-039173","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118039173/doc4.xml","form_type":"4"}},{"id":3891829,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2018-06-18T10:49:33.000Z","date":"2018-06-14","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest 1/3 per year annually over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":12500,"derivative":{"underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-18-008818","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008818/form4.xml","form_type":"4"}},{"id":3891828,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value per share","published_at":"2018-06-18T10:49:33.000Z","date":"2018-06-14","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001493152-18-008818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218008818/form4.xml","form_type":"4"}},{"id":3897433,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-12T22:05:15.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted on June 9, 2011 and vest in four equal installments beginning on June 9, 2012."}],"balance_after":0,"derivative":{"exercise_price":3.43,"expiration_date":"2018-06-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-037294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118037294/doc4.xml","form_type":"4"}},{"id":3897432,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2018-06-12T22:05:15.000Z","date":"2018-06-08","kind":"tax_withholding","acquired":false,"shares":63946,"price":4.26,"value":272409.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Company at the direction of the reporting person for payment of the exercise price and tax liability in connection with the exercise of the stock option.  No shares of Common stock were sold by the reporting person in connection with this transaction.  The reporting person has retained the net number of shares issued upon the exercise of the option, less the amount retained to pay the associated tax liability (11,054 of shares)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing market price of the Company's common stock on the transaction date."}],"balance_after":175912,"source":{"system":"sec-edgar","filing":"0001209191-18-037294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118037294/doc4.xml","form_type":"4"}},{"id":3897431,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2018-06-12T22:05:15.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":75000,"price":3.43,"value":257250.0,"ownership":{"direct":true},"balance_after":239858,"source":{"system":"sec-edgar","filing":"0001209191-18-037294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118037294/doc4.xml","form_type":"4"}},{"id":3996895,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2018-03-14T20:07:24.000Z","date":"2018-03-13","kind":"purchase","acquired":true,"shares":50,"price":3.4,"value":170.0,"ownership":{"direct":true},"balance_after":164858,"source":{"system":"sec-edgar","filing":"0001209191-18-019531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118019531/doc4.xml","form_type":"4"}},{"id":3996894,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2018-03-14T20:07:24.000Z","date":"2018-03-13","kind":"purchase","acquired":true,"shares":2015,"price":3.395,"value":6840.925,"ownership":{"direct":true},"balance_after":164808,"source":{"system":"sec-edgar","filing":"0001209191-18-019531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919118019531/doc4.xml","form_type":"4"}},{"id":4090484,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2018-01-25T15:26:26.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 23, 2018 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated January 23, 2018 (the \"Option Agreement\"). The options vest and become exercisable in 36 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":75000,"derivative":{"exercise_price":4.19,"expiration_date":"2028-01-23","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-18-001039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315218001039/form4.xml","form_type":"4"}},{"id":4186546,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":25000,"derivative":{"exercise_price":2.95,"exercise_date":"2018-10-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186545,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":18750,"derivative":{"exercise_price":2.95,"exercise_date":"2018-07-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186544,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":12500,"derivative":{"exercise_price":2.95,"exercise_date":"2018-04-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4186543,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-10-13T21:34:02.000Z","date":"2017-10-11","kind":"grant","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the \"Plan\"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date."}],"balance_after":6250,"derivative":{"exercise_price":2.95,"exercise_date":"2018-01-11","expiration_date":"2027-10-11","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001662252-17-000209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356197/000166225217000209/form4.xml","form_type":"4"}},{"id":4207579,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2017-09-18T10:09:58.000Z","date":"2017-09-15","kind":"purchase","acquired":true,"shares":1500,"price":6.03,"value":9045.0,"ownership":{"direct":true},"balance_after":162793,"source":{"system":"sec-edgar","filing":"0001209191-17-053087","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117053087/doc4.xml","form_type":"4"}},{"id":4280126,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (RSUs)","published_at":"2017-06-16T17:48:51.000Z","date":"2017-06-14","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest 1/3 per year over 3 years, beginning on June 14, 2017, subject to continued service through each vesting date."}],"balance_after":25000,"derivative":{"expiration_date":"2026-06-14","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-17-006770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006770/form4.xml","form_type":"4"}},{"id":4280125,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, no par value per share","published_at":"2017-06-16T17:48:51.000Z","date":"2017-06-14","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one common share. This transaction represents the settlement of restricted stock units in common shares on their scheduled vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001493152-17-006770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217006770/form4.xml","form_type":"4"}},{"id":4367640,"issuer":{"id":111039,"kind":"organization","name":"VBI Vaccines Inc/BC","symbol":"VBIV"},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy Common Shares)","published_at":"2017-03-31T20:10:46.000Z","date":"2017-03-30","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Incentive Plan (the \"Plan\"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the \"Grant Date\"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated March 30, 2017 (the \"Option Agreement\"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement."}],"balance_after":12500,"derivative":{"exercise_price":3.79,"expiration_date":"2027-01-26","underlying":"Common Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-17-003308","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/764195/000149315217003308/form4.xml","form_type":"4"}},{"id":4384948,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-13","kind":"exercise","acquired":false,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted on April 14, 2010 and vested in four equal installments beginning on April 14, 2011."}],"balance_after":0,"derivative":{"exercise_price":2.36,"expiration_date":"2017-04-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}},{"id":4384947,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-13","kind":"exercise","acquired":false,"shares":189207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option became exercisable in forty-eight (48) equal monthly installments until fully vested on March 15, 2011."}],"balance_after":0,"derivative":{"exercise_price":0.56,"expiration_date":"2017-03-15","underlying":"Common Stock","underlying_shares":189207},"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}},{"id":4384946,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-14","kind":"sale","acquired":false,"shares":112975,"price":8.0697,"value":911674.3575,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"All of the shares reported as disposed of in this Form 4 were sold to pay/satisfy federal and/or state tax withholding in connection with a stock option exercise on March 13, 2017. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.21, inclusive. The reporting person undertakes to provide to OPKO Health, Inc. (the \"Company\"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4."}],"balance_after":161293,"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}},{"id":4384945,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-13","kind":"tax_withholding","acquired":false,"shares":35728,"price":7.92,"value":282965.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (228,479 shares)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing market price of the Company's common stock on the transaction date."}],"balance_after":274268,"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}},{"id":4384944,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-13","kind":"exercise","acquired":true,"shares":75000,"price":2.36,"value":177000.0,"ownership":{"direct":true},"balance_after":309996,"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}},{"id":4384943,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":28376,"kind":"person","name":"Logal Adam","position":1,"cik":"0001356197","reported_name":"Logal Adam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. Vice President, CFO"}}],"security":"Common Stock","published_at":"2017-03-15T22:31:52.000Z","date":"2017-03-13","kind":"exercise","acquired":true,"shares":189207,"price":0.56,"value":105955.92,"ownership":{"direct":true},"balance_after":234996,"source":{"system":"sec-edgar","filing":"0001209191-17-020904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919117020904/doc4.xml","form_type":"4"}}]}